前列安方治疗慢性非细菌性前列腺炎肝郁血瘀证120例临床观察  

Clinical Observation on 120 Patients of Chronic Non-bacterial Prostatitis with the Syndrome of Liver Stagnation and Blood Stasis Treated by Qianliean Formula

作　　者：邹如政[1] 段华汛[1] 乐才文[1] 李青[1] 李莉娅[1] 李秀清[1] 

机构地区：[1]湖北中医学院附属襄樊医院,湖北省襄樊市长征路24号441000

出　　处：《中医杂志》2009年第6期516-518,共3页Journal of Traditional Chinese Medicine

基　　金：湖北省襄樊市科学技术局资助项目(2004-119)

摘　　要：目的观察前列安方治疗慢性非细菌性前列腺炎(CNP)肝郁血瘀证的临床疗效。方法将240例患者随机分为治疗组和对照组各120例,治疗组口服前列安方,对照组口服前列康片。观察两组的临床疗效,并于治疗前后进行慢性前列腺炎症状积分指数(NIH-CPSI)评分及前列腺液参数的检查。结果治疗组和对照组临床治愈率分别为38.33%和24.17%,总有效率分别为89.16%和64.67%,差异有统计学意义(P<0.01);在改善前列腺液参数、降低NIH-CPSI症状积分方面治疗组优于对照组(P<0.05或P<0.01)。结论前列安方治疗慢性非细菌性前列腺炎肝郁血瘀证有较好的临床疗效。Objective To observe the therapeutic effect of Qianliean Formula （formula for Improving Prostatitis） on chronic nonbacterial prostatitis in the syndrome of liver stagnation with blood stasis. Methods Totally 240 patients were randomized into the treatment group and control group with 120 cases in each. The former was treated with oral taking of Qianliean Formula while the latter treated by oral taking of Qianliekang Tablets. The therapeutic effect of both groups was observed, and the symptom scoring according to the chronic prostatitis symptom index given by National Institutes of Health （NIH-CPSI） and the examinations on parameters of prostatic fluid were carried out before and after treatment. Results The clinical curative rate of the treatment group and the control group was 38.33% and 24.17% respectively, the total effective rate was 89.16% and 64.67% respectively, the difference was significant （P〈0.01）. In improving the parameters of prostatic fluid and decreasing the NIH-CPSI scores, the treatment group was better than the control group （P〈0.05 or P〈0.01）. Conclusion Qianliean Formula is effective for the syndrome of liver stagnation with blood stasis in the chronic non-bacterial prostatitis.

关 键 词：慢性非细菌性前列腺炎 前列安 肝郁血瘀证 前列腺液 

分 类 号：R277.5[医药卫生—中医学]